tirzepatide off fda shortage list FDA's GLP-1 decision kicks 'unprecedented' tussle over US FDA Takes Lilly's Mounjaro,

Some clinicians prescribe phentermine for longer periods in an off-label capacity, cycling patients on and off the medication, but the official guidance remains firmly in the short-term camp

This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited

It attributes that approval to trials showing weight reduction and improved metabolic markers in that population, though it does not cite the specific trials by name

SingleCare savings cards can help you save money on your GLP-1s if Medicaid doesnt cover them

But, as I soon found out, the real risk wasnt losing excess weight: It was gaining it all back if I couldnt afford medication any longer